Product image of Kaptopril Krka (Captopril) supplied by GNH India

Kaptopril Krka

Active Ingredient:
Captopril
Origin:
EU

Kaptopril Krka (Captopril)

Captopril, the active ingredient in Kaptopril Krka, is an ACE inhibitor presented as an oral tablet for oral use. It treats hypertension, heart failure, post‑myocardial infarction and diabetic nephropathy in adult patients. It is indicated for patients requiring blood pressure control and for those with cardiovascular complications where inhibition of the renin‑angiotensin system is beneficial.

GNH India supplies Kaptopril Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company follows stringent quality standards and provides regulatory documentation to support import and distribution in multiple regions.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Captopril is used to manage conditions related to the renin‑angiotensin system and cardiovascular disease.
  • Hypertension: lowers systolic and diastolic blood pressure, reducing cardiovascular risk.
  • Heart failure: decreases afterload and improves symptoms and survival.
  • Post‑myocardial infarction: limits ventricular remodeling and reduces mortality.
  • Diabetic nephropathy: slows progression of renal impairment in patients with diabetes.

How It Works

  • Captopril selectively inhibits angiotensin‑converting enzyme (ACE), preventing the conversion of angiotensin I to the potent vasoconstrictor angiotensin II. This inhibition also reduces aldosterone secretion, leading to decreased sodium and water retention. The resulting vasodilation and lowered plasma volume lower systemic vascular resistance and arterial pressure, providing therapeutic benefit in hypertension and related cardiovascular conditions. Additionally, the reduced angiotensin II levels improve endothelial function and may attenuate pathological cardiac remodeling.

Side Effects

Captopril may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Cough: dry, persistent cough.
  • Taste disturbances: metallic or salty taste.
  • Rash: mild skin eruption.
  • Dizziness or light‑headedness.
  • Headache.

Serious or Rare Side Effects

  • Angioedema: swelling of face, lips, tongue or airway.
  • Severe hypotension: marked drop in blood pressure, especially after first dose.
  • Neutropenia or leukopenia: low white blood cell count.
  • Liver dysfunction: elevated transaminases or hepatitis.

Precautions & Warnings

  • Before initiating Captopril therapy, several safety considerations should be reviewed.
  • Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension.
  • Renal function assessment: evaluate serum creatinine and eGFR, adjust dose if impaired.
  • Electrolyte review: monitor potassium levels, especially if combined with potassium‑sparing agents.
  • Pregnancy warning: avoid use in pregnancy (Category D) due to risk of fetal toxicity.
  • Elderly caution: start with lower dose and titrate slowly in older patients.
  • Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Captopril can interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid)

  • Aliskiren: concurrent use in diabetes or renal impairment may increase risk of renal dysfunction.
  • Potassium‑sparing diuretics (e.g., spironolactone, amiloride): may cause hyperkalaemia.
  • Dual ACE/ARB therapy: combined use can lead to severe hypotension and renal impairment.

Moderate Interactions (Monitor Closely)

  • NSAIDs: may blunt antihypertensive effect and affect renal function.
  • Lithium: Captopril may increase lithium levels, risking toxicity.
  • Other antihypertensives (e.g., beta‑blockers, diuretics): may enhance blood pressure lowering, requiring dose adjustments.

Frequently Asked Questions

Kaptopril Krka contains captopril, an ACE inhibitor indicated for hypertension, chronic heart failure, post‑myocardial infarction management, and diabetic nephropathy. It works by lowering blood pressure and reducing strain on the heart and kidneys, helping to prevent complications associated with these cardiovascular and renal disorders.

Captopril blocks the angiotensin‑converting enzyme, which stops the conversion of angiotensin I into angiotensin II, a powerful vasoconstrictor. By reducing angiotensin II levels, it promotes vasodilation, decreases aldosterone‑mediated fluid retention, and ultimately lowers systemic blood pressure and cardiac afterload.

The appropriate dose of Kaptopril Krka is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and renal function. Dosage adjustments may be needed for elderly patients or those with impaired kidney function, and the prescriber will provide specific instructions.

Captopril is classified as Pregnancy Category D, indicating evidence of fetal risk and it should be avoided during pregnancy. Limited data are available for breastfeeding; therefore, the benefits and risks must be carefully evaluated by a healthcare professional before use in nursing mothers.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Kaptopril is a first‑generation ACE inhibitor with a sulfhydryl group, which can cause a higher incidence of taste disturbances and cough compared with later agents such as enalapril or lisinopril. However, its efficacy in lowering blood pressure and providing cardioprotective benefits is comparable across the class.

Kaptopril Krka should be stored at room temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain stability and potency throughout its shelf life.

Kaptopril Krka is taken orally, usually with or without food as directed by the prescriber. Tablets should be swallowed whole with a full glass of water. Patients should follow the dosing schedule provided by their healthcare professional and not alter the regimen without consultation.

The most serious adverse reactions include angioedema, which can cause swelling of the face, lips, tongue or airway, and severe hypotension, especially after the first dose. Prompt medical attention is required if any signs of these conditions appear.

Kaptopril Krka should be avoided in patients with a known hypersensitivity to captopril or other ACE inhibitors, those with a history of angioedema related to ACE‑inhibitor therapy, and pregnant women. Caution is also advised for individuals with severe renal impairment or hyperkalaemia.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Captopril

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT